The proposed cash-and-stock acquisition will add treatments for uncommon blood and immunological disorders to the portfolio of the Cambridge-based drugmaker.
India’s AI-for-public-good trajectory reveals a pattern of pragmatic, use-case-driven development that is capitalising on the country’s growing innovation ecosystem and tech-adaptive populace.
Low salaries, little growth in corporate jobs and F&O losses, the assumptions that once built middle class security are no longer applicable to the emerging Indian economy.
COMMENTS